Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Malignant Solid Tumors 1

Interventions

Specimen Handling 113Magnetic Resonance Spectroscopy 78Biopsy 78pembrolizumab 61Cyclophosphamide 52fludarabine 43Carboplatin 26Nivolumab 24Cetuximab 24Cisplatin 23venetoclax 22Radiotherapy 21Bevacizumab 21atezolizumab 18X-Rays 18fludarabine phosphate 17Radiation 17Ipilimumab 17Fluorouracil 17Gemcitabine 16Paclitaxel 15Leucovorin 15Cytarabine 15Temozolomide 14Pemetrexed 14Irinotecan 14durvalumab 13Oxaliplatin 13Azacitidine 13Prednisone 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Premedication × 30 days × Clear all
NCT06573294 2026-05-20

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Genmab

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡